Ikena Oncology Inc (IKNA)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart
Ticker: IKNA Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-01-12 2022-01-11 PS Planned sale

Zhang Xiaoyan Michelle

Chief Scientific Officer

Officer
964 -2.1%
12.00
USD 11,568 		964 -2.1% 12.00 USD 11,568
2022-01-12 2022-01-10 PS Planned sale

Zhang Xiaoyan Michelle

Chief Scientific Officer

Officer
36 -0.1%
12.00
USD 432 		36 -0.1% 12.00 USD 432
2021-12-14 2021-12-14 S Sale

FORMELA JEAN FRANCOIS

Non-Executive Director
5,959 -0.5%
14.00
USD 83,426 		5,959 -0.5% 14.00 USD 83,426
2021-12-14 2021-12-14 S Sale

Atlas Venture Fund XI, L.P.

Large shareholder
5,959 -0.5%
14.00
USD 83,426 		5,959 -0.5% 14.00 USD 83,426
2021-12-14 2021-12-13 S Sale

FORMELA JEAN FRANCOIS

Non-Executive Director
8,330 -0.7%
14.64
USD 121,951 		8,330 -0.7% 14.64 USD 121,951
2021-12-14 2021-12-13 S Sale

Atlas Venture Fund XI, L.P.

Large shareholder
8,330 -0.7%
14.64
USD 121,951 		8,330 -0.7% 14.64 USD 121,951
2021-12-14 2021-12-10 S Sale

Zhang Xiaoyan Michelle

Chief Scientific Officer

Officer
1,000 -2.2%
14.76
USD 14,760 		1,000 -2.2% 14.76 USD 14,760
2021-12-14 2021-12-10 S Sale

FORMELA JEAN FRANCOIS

Non-Executive Director
11,989 -0.9%
15.03
USD 180,195 		11,989 -0.9% 15.03 USD 180,195
2021-12-14 2021-12-10 S Sale

Atlas Venture Fund XI, L.P.

Large shareholder
11,989 -0.9%
15.03
USD 180,195 		11,989 -0.9% 15.03 USD 180,195
2021-12-14 2021-03-30 B Purchase

FORMELA JEAN FRANCOIS

Non-Executive Director
125,000 +16.7%
16.00
USD 2,000,000 		125,000 +16.7% 16.00 USD 2,000,000
2021-12-14 2021-03-30 B Purchase

Atlas Venture Fund XI, L.P.

Large shareholder
125,000 +16.7%
16.00
USD 2,000,000 		125,000 +16.7% 16.00 USD 2,000,000
2021-04-01 2021-03-30 B Purchase

ORBIMED ADVISORS LLC

Non-Executive Director
48,400 +70.2%
16.00
USD 774,400 		48,400 +70.2% 16.00 USD 774,400
2021-04-01 2021-03-30 B Purchase

ORBIMED ADVISORS LLC

Non-Executive Director
375,000 +20.6%
16.00
USD 6,000,000 		375,000 +20.6% 16.00 USD 6,000,000
2021-04-01 2021-03-30 B Purchase

Bonita David P

Non-Executive Director
48,400 +70.2%
16.00
USD 774,400 		48,400 +70.2% 16.00 USD 774,400
2021-04-01 2021-03-30 B Purchase

Bonita David P

Non-Executive Director
375,000 +20.6%
16.00
USD 6,000,000 		375,000 +20.6% 16.00 USD 6,000,000
// ... existing code ... // ... rest of the file ...